↑ Read the latest from the desks · fresh intelligence, published daily✦Quiet reading✦No ads, ever✦Ad-free articles read by humans today …↑✦Boards engagement today … people · … AI✦Corporate brand & media services✦Made in Virginia Beach since 1997✦
Healthcare PE deployed **$191B** in 2025, targeting physician roll-ups and AI infrastructure with tighter entry discipline than 2021.
$191 billion
in 2025
14% increase
over 2021's
$167 billion
and reverses the sector's post-pandemic contraction when rising rates…
$5.8 billion
take-private of Option Care Health on Tuesday
Global healthcare private equity deployed $191 billion in 2025, clearing the previous high set in 2021 and ending a two-year drought in capital formation, according to Bain & Company's latest transaction review. The figure marks a 14% increase over 2021's $167 billion and reverses the sector's post-pandemic contraction when rising rates froze exit windows and valuation gaps widened.
The capital moved into two primary channels: physician practice management platforms and AI-enabled infrastructure plays. Firms including CD&R and McKesson announced a $5.8 billion take-private of Option Care Health on Tuesday, the largest single infusion therapy transaction since 2019. GTCR closed a $1.0 billion acquisition of PE-backed Tactacam the same week, illustrating appetite for vertical integration in specialty care. Bain's data shows practice management roll-ups accounted for 38% of total deal value, up from 22% in 2023, as sponsors bet on consolidation arbitrage in fragmented specialties—dermatology, gastroenterology, ophthalmology.
The second driver was AI integration, particularly in revenue cycle management and clinical workflow automation. Sponsors allocated an estimated $47 billion to companies layering machine learning into billing, prior authorization, and diagnostic triage—domains where labor cost and error rates create arbitrage. Firms see margin expansion of 200 to 400 basis points over three years when AI tools replace manual coding and claims adjudication. The shift reflects a broader thesis: healthcare's administrative bloat is software-fixable, and the sector's $1.2 trillion annual spend on non-clinical overhead is addressable.
What separates this cycle from 2021 is entry discipline. Median EV/EBITDA multiples for platform deals held at 11.2x in 2025, down from 13.8x in 2021, per PitchBook. Sponsors underwrote to 12-14% IRRs instead of the 18-22% targets that drove the prior peak, acknowledging that exit multiples will compress and growth must come from operational torque rather than multiple arbitrage. Leverage stayed contained at 5.1x net debt to EBITDA, below the 6.3x average in 2021, as lenders imposed tighter covenants on healthcare services credits.
The volume also signals that limited partners unfroze capital calls. Healthcare-focused funds raised $68 billion in 2024, the highest vintage year since 2020, and LPs deployed that dry powder into a sector with defensive cash flows and demographic tailwinds. The 65-and-older cohort in the U.S. will grow by 16 million people through 2030, ensuring demand for specialty care and chronic disease management regardless of macro conditions.
Operators and allocators should track three follow-on developments over the next six to nine months. First, whether the Federal Trade Commission moves to block physician practice roll-ups under its updated merger guidelines—Commissioner Lina Khan has flagged consolidation in dermatology and anesthesiology as enforcement priorities. Second, how Medicare Advantage rate adjustments in early 2026 affect valuations for companies tied to MA reimbursement, which funds 42% of specialty care revenue. Third, whether AI-enabled platforms deliver the promised margin lift or whether implementation costs and change-management friction erode the thesis.
The $191 billion is not a sentiment indicator. It is a deployment fact in a sector where the next decade's returns will separate sponsors who bought workflow efficiency from those who bought PowerPoint decks.
Branded by POPS4 · proof in 60 seconds
For the principal
Watch FTC enforcement on practice consolidation and Medicare Advantage rate changes—both could reprice portfolios within twelve months.
For the operator
Underwrite AI margin lift claims with vendor references and implementation timelines—half the pitch decks are aspirational, not operational.
For the house
We are rotating Huang Goodman Healthcare Fund toward revenue-cycle plays with audited pre-AI baselines and away from specialty roll-ups in FTC crosshairs.
The branded-identity layer Chiefs of Staff and heritage CMOs route through — your name imprinted on real authorized stock, your pick of 200+ brands and 70,000 products, shipped from one accountable house. Nine editorial desks publish the intelligence those operators read before they sign.
200+authorized brands
70,000products · virtual proof on each
9 deskspublishing daily
1997one house, since
70,000 SKUs · virtual proof in 60 seconds · no platform fee · blind-shipped · ASI #217876
Your next customer won't visit your website. Their AI will.
AI assistants have quietly taken over the first step of buying — they answer from catalogs they can read and shortlist whoever can actually ship. Two questions now decide whether you exist to that buyer: can a machine read your catalog, and can you fulfill the order. Most brands fail one or both and never find out why the orders went elsewhere. The winners of this shift aren't the loudest. They're the most readable. Build for the machine that's about to do the shopping.
Built by the craft floor — apparel, media, packaging, and secure print.
This trade runs on hands, not desks. Imprint manufacturing & Komori heritage press through approved vendors · Canon high-speed secure-media operations is a craft floor — genuine Six Sigma discipline applied to ink, thread, foil, and registration, where a hundredth of an inch is the difference between a brand that reads serious and one that reads cheap. POPS4 is built by exactly those operators: independent, boots-on-the-ground engineers who carry their own book, read a client in microseconds, and put their name on every run. Beyond our own Virginia Beach floor, we work with a vetted network of craft manufacturers across the US — each meeting the highest excellence in QC standards in the industry, each a specialist in its own discipline — so apparel, hard-goods imprinting, media manufacturing, packaging, and secure printing all go to the bench built for them, coordinated from one accountable hub. Short-run from twenty-five units, volume to five hundred thousand. Two hundred authorized national brands, seventy thousand SKUs with virtual proofing on every one. Art archived for instant reorders. Net-thirty corporate terms, NDA-standard white-label — your name on the work, or none at all.
Strategy, positioning, identity, creative, and messaging — wired into an AI system that publishes and distributes on its own. Nine editorial desks generate the authority, the production house ships the physical proof, and the attribution layer tells you which post sold which SKU. What you get is an operating layer — content, catalog, and order path under one roof — that keeps working whether or not you are in the room. Built for principals who would rather own the machine than rent the agency.
Named-account programs — one desk, quiet delivery, NDA-standard.
One point of contact who already knows the file, so nothing restarts from zero between engagements. The work ships blind, under NDA, with your name on it or none at all. Built for single-family offices, heritage-house CMOs, sports-ownership groups, and the agencies that white-label our production. The relationship is the product; the merch is the proof of it.
SFO · Chief of Staff desk. Principal household, properties, aircraft, yacht, calendar, philanthropy — one file.
Shop seventy thousand products. Virtual proof on every one. 24/7.
Drop your logo on any product and see the virtual proof before asking. Quote routes direct to the desk. MCP catalog for AI agents. Celeste for the fast conversation. Full self-service checkout in development.